BlinkLab
Announcements

Read our recent announcements about our company, our research, and partnerships.

Commencement of Pivotal Validation Program for FDA 510(k) Submission: First Participant Enrolled

BlinkLab announced the commencement of its validation program supporting 510(k) submission, with the first child participant now enrolled and having completed initial testing using BlinkLab Dx1.

Henk-Jan Boele, MD, PhD

•

March 24, 2026

In the news

View all

March 31, 2026

Gia Le from East Coast Research interviews Dr Henk-Jan Boele about BlinkLab's commercial and regulatory position.

Read the article

March 29, 2026

Kalkine's deep-dive on BlinkLab as an example of healthcare innovation in digital neurological screening systems.

Read the article

March 27, 2026

Scott Power: ASX healthcare breaks losing streak in good news week

Read the article

March 25, 2026

With the help of Australian company, BlinkLab, Morocco launches a groundbreaking early screening program (Translation)

Read the article

Read all announcements

Commencement of Pivotal Validation Program for FDA 510(k) Submission: First Participant Enrolled

BlinkLab announced the commencement of its validation program supporting 510(k) submission, with the first child participant now enrolled and having completed initial testing using BlinkLab Dx1.

Henk-Jan Boele, MD, PhD

•

Mar 24, 2026

BlinkLab Selected for Morocco’s Nationwide Government-Funded Autism Screening Program

BlinkLab announces its involvement in a landmark national autism screening and capacity-building initiative launched by the Kingdom of Morocco.

Henk-Jan Boele, MD, PhD

•

Mar 23, 2026

Completion of Clinical Trial Network for Pivotal FDA Study with Addition of Tenth Clinical Site – University of Arkansas

BlinkLab announces the onboarding of University of Arkansas as the tenth and final clinical site for the Company’s upcoming pivotal U.S. regulatory trial for BlinkLab Dx 1.

Henk-Jan Boele, MD, PhD

•

Mar 16, 2026

Partnership with SHANK2 Autism Foundation in the United States

Formation of new partnership with the SHANK2 Foundation, a U.S.-based not-for-profit organisation with a focus on advocacy, awareness, the creation of research infrastructure.

Henk-Jan Boele, MD, PhD

•

Mar 13, 2026

Expansion of Pivotal FDA Trial Network to Nine Elite U.S. Sites Ahead of Imminent Study Commencement – Drexel Univerisity

BlinkLab announced that Drexel University has joined as a clinical site for the Company’s pivotal U.S. regulatory trial for BlinkLab Dx 1.

Henk-Jan Boele, MD, PhD

•

Feb 12, 2026

BlinkLab Invited to Present at Simons Foundation Autism Research Initiative (SFARI) Event

Managing Director & CEO of BlinkLab Limited, Dr Henk-Jan Boele, has been invited to speak at a prestigious in-person scientific workshop hosted by the SimonsFoundation Autism Research Initiative (SFARI) in New York City, USA.

Henk-Jan Boele, MD, PhD

•

Jan 23, 2026

BlinkLab Receives $822,205 R&D Tax Incentive Refund

BlinkLab receives R&D Tax Incentive Refund relating to its U.S. Pilot Study and Australian clinical research initatives

Henk-Jan Boele, MD, PhD

•

Jan 8, 2026

High-Profile Journal Publication Validates BlinkLab's Technology

High-profile publication in leading journal "Autism Research" validates BlinkLab’s technology, providing support for future clinical adoption

Henk-Jan Boele, MD, PhD

•

Jan 5, 2026

Rush University Medical Center Joins BlinkLab’s Pivotal U.S. Autism Diagnostic Trial

BlinkLab announces Rush as eighth premier U.S. autism center for F1DA 510(k) trial of smartphone-based diagnostic aid, with first expected subjects in Q1 2026.

Henk-Jan Boele, MD, PhD

•

Nov 13, 2025

Want to feature BlinkLab?

We are more than happy to assist you with that. If you need any assets, insights or want to request an interview — feel free to reach out to Henk-Jan, our CEO.

Send Henk-Jan an email

BlinkLab
Announcements

Commencement of Pivotal Validation Program for FDA 510(k) Submission: First Participant Enrolled

In the news

Gia Le from East Coast Research interviews Dr Henk-Jan Boele about BlinkLab's commercial and regulatory position.

Kalkine's deep-dive on BlinkLab as an example of healthcare innovation in digital neurological screening systems.

Scott Power: ASX healthcare breaks losing streak in good news week

With the help of Australian company, BlinkLab, Morocco launches a groundbreaking early screening program (Translation)

Read all announcements

Commencement of Pivotal Validation Program for FDA 510(k) Submission: First Participant Enrolled

BlinkLab Selected for Morocco’s Nationwide Government-Funded Autism Screening Program

Completion of Clinical Trial Network for Pivotal FDA Study with Addition of Tenth Clinical Site – University of Arkansas

Partnership with SHANK2 Autism Foundation in the United States

Expansion of Pivotal FDA Trial Network to Nine Elite U.S. Sites Ahead of Imminent Study Commencement – Drexel Univerisity

BlinkLab Invited to Present at Simons Foundation Autism Research Initiative (SFARI) Event

BlinkLab Receives $822,205 R&D Tax Incentive Refund

High-Profile Journal Publication Validates BlinkLab's Technology

Rush University Medical Center Joins BlinkLab’s Pivotal U.S. Autism Diagnostic Trial

Want to feature BlinkLab?

Help us improve diagnostic evaluations for autism

Awesome! You're now signed up.

BlinkLabAnnouncements

Commencement of Pivotal Validation Program for FDA 510(k) Submission: First Participant Enrolled

In the news

Gia Le from East Coast Research interviews Dr Henk-Jan Boele about BlinkLab's commercial and regulatory position.

Kalkine's deep-dive on BlinkLab as an example of healthcare innovation in digital neurological screening systems.

Scott Power: ASX healthcare breaks losing streak in good news week

With the help of Australian company, BlinkLab, Morocco launches a groundbreaking early screening program (Translation)

Read all announcements

Commencement of Pivotal Validation Program for FDA 510(k) Submission: First Participant Enrolled

BlinkLab Selected for Morocco’s Nationwide Government-Funded Autism Screening Program

Completion of Clinical Trial Network for Pivotal FDA Study with Addition of Tenth Clinical Site – University of Arkansas

Partnership with SHANK2 Autism Foundation in the United States

Expansion of Pivotal FDA Trial Network to Nine Elite U.S. Sites Ahead of Imminent Study Commencement – Drexel Univerisity

BlinkLab Invited to Present at Simons Foundation Autism Research Initiative (SFARI) Event

BlinkLab Receives $822,205 R&D Tax Incentive Refund

High-Profile Journal Publication Validates BlinkLab's Technology

Rush University Medical Center Joins BlinkLab’s Pivotal U.S. Autism Diagnostic Trial

Want to feature BlinkLab?

Help us improve diagnostic evaluations for autism

Subscribe to the newsletter

Awesome! You're now signed up.

BlinkLab
Announcements